PetMed Express (PETS) Stock Forecast, Price & News

PetMed Express (NASDAQ:PETS) Frequently Asked Questions

Is PetMed Express a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for PetMed Express in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" PetMed Express stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PETS, but not buy additional shares or sell existing shares.
View analyst ratings for PetMed Express or view top-rated stocks.

When is PetMed Express' next earnings date?

PetMed Express is scheduled to release its next quarterly earnings announcement on Monday, July 25th 2022.
View our earnings forecast for PetMed Express.

How were PetMed Express' earnings last quarter?

PetMed Express, Inc. (NASDAQ:PETS) posted its quarterly earnings data on Monday, May, 9th. The company reported $0.30 earnings per share for the quarter, topping analysts' consensus estimates of $0.27 by $0.03. The firm had revenue of $66 million for the quarter, compared to the consensus estimate of $67.80 million. PetMed Express had a trailing twelve-month return on equity of 15.45% and a net margin of 7.72%. During the same quarter in the previous year, the company earned $0.34 EPS.
View PetMed Express' earnings history.

How often does PetMed Express pay dividends? What is the dividend yield for PetMed Express?

PetMed Express announced a quarterly dividend on Monday, May 9th. Investors of record on Friday, May 20th will be paid a dividend of $0.30 per share on Friday, May 27th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.02%. The ex-dividend date is Thursday, May 19th.
View PetMed Express' dividend history.

Is PetMed Express a good dividend stock?

PetMed Express pays an annual dividend of $1.20 per share and currently has a dividend yield of 5.94%. PETS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. PetMed Express has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of PetMed Express is 115.39%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, PetMed Express will have a dividend payout ratio of 110.09% in the coming year. This indicates that PetMed Express may not be able to sustain their current dividend.
View PetMed Express' dividend history.

What price target have analysts set for PETS?

3 equities research analysts have issued twelve-month target prices for PetMed Express' shares. Their forecasts range from $21.00 to $32.00. On average, they anticipate PetMed Express' share price to reach $27.00 in the next year. This suggests a possible upside of 35.3% from the stock's current price.
View analysts' price targets for PetMed Express or view top-rated stocks among Wall Street analysts.

Who are PetMed Express' key executives?

PetMed Express' management team includes the following people:

• Mr. Bruce S. Rosenbloom, CFO & Treasurer (Age 53, Pay $473.47k) (LinkedIn Profile)
• Mr. Matthew N. Hulett, CEO, Pres & Director (Age 51)
• Mr. Mark Moseley, Chief Technology & Information Officer
• Mr. Daniel Job Pingree, Chief Marketing Officer
• Ms. Jacqueline Smith, VP of People
• Wendy Zalai, Corp. Controller & Corp. Sec.

What is Mendo Akdag's approval rating as PetMed Express' CEO?

5 employees have rated PetMed Express CEO Mendo Akdag on Glassdoor.com. Mendo Akdag has an approval rating of 46% among PetMed Express' employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of PetMed Express' key competitors?

Some companies that are related to PetMed Express include Amazon.com (AMZN), Booking (BKNG), Netflix (NFLX), Expedia Group (EXPE), Tripadvisor (TRIP), Overstock.com (OSTK), 1-800-FLOWERS.COM (FLWS), CarParts.com (PRTS) and Groupon (GRPN).
View all of PETS's competitors.

What other stocks do shareholders of PetMed Express own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Verizon Communications (VZ), Netflix (NFLX) and Micron Technology (MU).

What is PetMed Express' stock symbol?

PetMed Express trades on the NASDAQ under the ticker symbol "PETS."

Who are PetMed Express' major shareholders?

PetMed Express' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.91%), Vanguard Group Inc. (6.85%), Renaissance Technologies LLC (4.64%), ProShare Advisors LLC (4.36%), State Street Corp (4.35%) and Dimensional Fund Advisors LP (2.70%). Company insiders that own PetMed Express stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Ronald J Korn.
View institutional ownership trends for PetMed Express.

Which institutional investors are selling PetMed Express stock?

PETS stock was sold by a variety of institutional investors in the last quarter, including J. Goldman & Co LP, State Street Corp, Group One Trading L.P., Penserra Capital Management LLC, ProShare Advisors LLC, Allianz Asset Management GmbH, Bahl & Gaynor Inc., and Simplex Trading LLC.
View insider buying and selling activity for PetMed Express or view top insider-selling stocks.

Which institutional investors are buying PetMed Express stock?

PETS stock was purchased by a variety of institutional investors in the last quarter, including Mirae Asset Global Investments Co. Ltd., Renaissance Technologies LLC, Goldman Sachs Group Inc., Walleye Trading LLC, BlackRock Inc., Charles Schwab Investment Management Inc., Fisher Asset Management LLC, and Vanguard Group Inc..
View insider buying and selling activity for PetMed Express or or view top insider-buying stocks.

How do I buy shares of PetMed Express?

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PetMed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $19.95.

How much money does PetMed Express make?

PetMed Express has a market capitalization of $418.55 million and generates $273.42 million in revenue each year. The company earns $21.10 million in net income (profit) each year or $1.039990 on an earnings per share basis.

How many employees does PetMed Express have?

PetMed Express employs 219 workers across the globe.

When was PetMed Express founded?

PetMed Express was founded in 1996.

What is PetMed Express' official website?

The official website for PetMed Express is www.1800petmeds.com.

How can I contact PetMed Express?

PetMed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at (561) 526-4444, via email at [email protected], or via fax at 561-526-4445.